Sameer Sah, is an experienced practitioner, currently working with the Corporate / M&A team of Khaitan & Co, and working at the firmâ€™s Mumbai office. He has handled a variety of matters, particularly in the areas of strategic M&A, foreign investments, private equity, and regulatory approvals for investing in India. Separately, Sameer is also a member of the pharmaceuticals and healthcare practice group of the firm and advises clients on regulatory and other issues pertaining to the pharmaceuticals and healthcare industry.
Chambers Asia Pacific 2012 has labeled Sameer as an associate "to watch" and notes that sources single him out for being "solution-oriented and pragmatic". AsiaLaw 2013 and 2014 note him as a "Leading Lawyer" in India. Leading publications such as Mint, Express Pharma, DNA, Financial Chronicle, etc., have quoted him on issues pertaining to pharmaceutical sector. In the past, Sameer has worked with Majmudar & Co, International Lawyers, with the Corporate and Tax practice. Admitted to practice law since 2007, Sameer holds a Bachelorsâ€™ Degree in Science and Law with honours in Corporate Legal Studies from National Law University, Jodhpur.